Procter & Gamble (PG) Stock Forecast & Price Target

$168.06 -1.13 (-0.67%)

(As of 12/20/2024 05:31 PM ET)

Procter & Gamble - Analysts' Recommendations and Stock Price Forecast (2025)

MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0 to .5 = Strong Sell, .5 to 1 = Sell, 1 to 1.5 = Reduce, 1.5 to 2.5 = Hold, 2.5 to 3.0 = Moderate Buy, 3.0 to 3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.

Consensus Rating

Moderate Buy

Based on 23 Analyst Ratings

Sell
0

Hold
7

Buy
16

Based on 23 Wall Street analysts who have issued ratings for Procter & Gamble in the last 12 months, the stock has a consensus rating of "Moderate Buy." Out of the 23 analysts, 7 have given a hold rating, 14 have given a buy rating, and 2 have given a strong buy rating for PG.

Consensus Price Target

$180.45
7.37% Upside

According to the 23 analysts' twelve-month price targets for Procter & Gamble, the average price target is $180.45. The highest price target for PG is $209.00, while the lowest price target for PG is $161.00. The average price target represents a forecasted upside of 7.37% from the current price of $168.06.

Get the Latest News and Ratings for PG and Related Stocks

Enter your email address to receive the latest news and analysts' ratings for Procter & Gamble and its competitors.

PG Analyst Ratings Over Time

Type	Current Forecast 12/22/23 to 12/21/24	1 Month Ago 11/22/23 to 11/21/24	3 Months Ago 9/23/23 to 9/22/24	1 Year Ago 12/22/22 to 12/22/23
Strong Buy	2 Strong Buy rating(s)	2 Strong Buy rating(s)	1 Strong Buy rating(s)	0 Strong Buy rating(s)
Buy	14 Buy rating(s)	13 Buy rating(s)	14 Buy rating(s)	12 Buy rating(s)
Hold	7 Hold rating(s)	8 Hold rating(s)	6 Hold rating(s)	6 Hold rating(s)
Sell	0 Sell rating(s)	0 Sell rating(s)	0 Sell rating(s)	0 Sell rating(s)
Consensus Price Target	$180.45	$177.00	$176.16	$166.41
Forecasted Upside	7.37% Upside	2.50% Upside	1.11% Upside	14.52% Upside
Consensus Rating	Moderate Buy	Moderate Buy	Moderate Buy	Moderate Buy

URGENT: This Altcoin Opportunity Won’t Wait – Act Now (Ad)

Crypto has officially entered the "banana zone" – that wild phase where prices can 1000x in days. It happens like clockwork every 4 years, during the December to February window of a Bitcoin halving year. This is where fortunes are made – often LITERALLY overnight.

>> Register for the Workshop Now

PG Analyst Recommendations By Month

The chart below shows how a company's ratings by analysts have changed over time. Each bar represents the previous year of ratings for that month. Within each bar, the sell ratings are shown in red, the hold ratings are shown in yellow, the buy ratings are shown in green, and the strong buy ratings are shown in dark green.

PG Price Targets by Month

The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.

Procter & Gamble Stock vs. The Competition

Type	Procter & Gamble	Consumer Staples Companies	S&P 500
Consensus Rating Score	2.78	2.50	2.51
Consensus Rating	Moderate Buy	Hold	Moderate Buy
Predicted Upside	7.37% Upside	46.09% Upside	14.54% Upside
News Sentiment Rating	Positive News See Recent PG News	Positive News	Positive News

Recent Analyst Forecasts and Stock Ratings

Rating

Upside/Downside

Action

Time Frame

Start Date

End Date

Show

Export to Excel

Date	Brokerage	Analyst Name	Action	Rating	Price Target	Upside/Downside on Report Date
11/25/2024	DA Davidson 3 of 5 stars	L. Weiser Subscribe to MarketBeat All Access for the recommendation accuracy rating	Upgrade	Neutral ➝ Buy	$160.00 ➝ $209.00	+18.56%
11/22/2024	Wells Fargo & Company 3 of 5 stars		Boost Target	Overweight ➝ Overweight	$188.00 ➝ $190.00	+9.67%
10/21/2024	Morgan Stanley 3 of 5 stars		Boost Target	Overweight ➝ Overweight	$174.00 ➝ $191.00	+12.88%
10/21/2024	Evercore ISI Subscribe to MarketBeat All Access for the recommendation accuracy rating		Boost Target	Outperform ➝ Outperform	$180.00 ➝ $183.00	+8.25%
10/21/2024	Royal Bank of Canada Subscribe to MarketBeat All Access for the recommendation accuracy rating		Reiterated Rating	Sector Perform ➝ Sector Perform	$164.00 ➝ $164.00	-3.77%
10/4/2024	Hsbc Global Res Subscribe to MarketBeat All Access for the recommendation accuracy rating	A. Zamacona Subscribe to MarketBeat All Access for the recommendation accuracy rating	Upgrade	Strong-Buy
Get the Latest News and Ratings for PG and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for Procter & Gamble and its competitors with MarketBeat's FREE daily newsletter.
9/30/2024	Barclays Subscribe to MarketBeat All Access for the recommendation accuracy rating	L. Lieberman Subscribe to MarketBeat All Access for the recommendation accuracy rating	Downgrade	Overweight ➝ Equal Weight	$163.00 ➝ $163.00	-6.08%
9/24/2024	Piper Sandler Subscribe to MarketBeat All Access for the recommendation accuracy rating		Initiated Coverage	Neutral	$174.00	+0.13%
9/19/2024	JPMorgan Chase & Co. Subscribe to MarketBeat All Access for the recommendation accuracy rating		Boost Target	Overweight ➝ Overweight	$179.00 ➝ $186.00	+8.84%
8/29/2024	DZ Bank Subscribe to MarketBeat All Access for the recommendation accuracy rating		Upgrade	Hold ➝ Buy	$190.00	+12.36%
8/23/2024	Wolfe Research Subscribe to MarketBeat All Access for the recommendation accuracy rating	G. Badishkanian Subscribe to MarketBeat All Access for the recommendation accuracy rating	Upgrade	Strong-Buy
8/1/2024	Dbs Bank Subscribe to MarketBeat All Access for the recommendation accuracy rating	C. Widjaja Subscribe to MarketBeat All Access for the recommendation accuracy rating	Downgrade	Strong-Buy ➝ Hold
7/24/2024	Jefferies Financial Group Subscribe to MarketBeat All Access for the recommendation accuracy rating		Downgrade	Buy ➝ Hold	$182.00 ➝ $175.00	+5.03%
7/23/2024	TD Cowen Subscribe to MarketBeat All Access for the recommendation accuracy rating	R. Moskow Subscribe to MarketBeat All Access for the recommendation accuracy rating	Initiated Coverage	Buy	$189.00	+12.31%
7/22/2024	Stifel Nicolaus Subscribe to MarketBeat All Access for the recommendation accuracy rating		Boost Target	Hold ➝ Hold	$157.00 ➝ $161.00	-4.14%
7/17/2024	Deutsche Bank Aktiengesellschaft Subscribe to MarketBeat All Access for the recommendation accuracy rating		Boost Target	Buy ➝ Buy	$171.00 ➝ $176.00	+4.13%
7/10/2024	Citigroup Subscribe to MarketBeat All Access for the recommendation accuracy rating		Boost Target	Buy ➝ Buy	$177.00 ➝ $190.00	+13.96%
6/24/2024	BNP Paribas Subscribe to MarketBeat All Access for the recommendation accuracy rating	K. Grundy Subscribe to MarketBeat All Access for the recommendation accuracy rating	Initiated Coverage	Outperform	$187.00	+11.14%
4/25/2024	Argus Subscribe to MarketBeat All Access for the recommendation accuracy rating		Boost Target	Buy ➝ Buy	$180.00 ➝ $185.00	+13.49%
3/11/2024	Truist Financial Subscribe to MarketBeat All Access for the recommendation accuracy rating		Upgrade	Hold ➝ Buy	$160.00 ➝ $175.00	+9.14%
3/1/2024	The Goldman Sachs Group Subscribe to MarketBeat All Access for the recommendation accuracy rating		Initiated Coverage	Neutral	$168.00	+5.70%
1/24/2024	UBS Group Subscribe to MarketBeat All Access for the recommendation accuracy rating		Boost Target	Buy ➝ Buy	$172.00 ➝ $178.00	+15.85%
1/24/2024	Raymond James Subscribe to MarketBeat All Access for the recommendation accuracy rating		Boost Target	Outperform ➝ Outperform	$170.00 ➝ $175.00	+13.65%
10/12/2023	Sanford C. Bernstein Subscribe to MarketBeat All Access for the recommendation accuracy rating		Lower Target	Market Perform ➝ Market Perform	$162.00 ➝ $153.00	+7.02%
9/22/2023	HSBC Subscribe to MarketBeat All Access for the recommendation accuracy rating		Initiated Coverage	Buy	$179.00	+17.64%
9/8/2023	William Blair Subscribe to MarketBeat All Access for the recommendation accuracy rating	J. Andersen Subscribe to MarketBeat All Access for the recommendation accuracy rating	Initiated Coverage	Market Perform
8/1/2023	Bank of America Subscribe to MarketBeat All Access for the recommendation accuracy rating		Boost Target	Buy ➝ Buy	$170.00 ➝ $175.00	+11.96%

Analyst ratings data on MarketBeat is provided by Benzinga and other data providers. This page was last refreshed on Saturday at 08:35 PM ET.

Should I Buy Procter & Gamble Stock? PG Pros and Cons Explained

These pros and cons were generated based on recent news and financial data from MarketBeat in order to provide readers with the fastest and most accurate insights. They were last updated on Sunday, December 15, 2024. Please send any questions or comments about these Procter & Gamble pros and cons to contact@marketbeat.com.

Procter & Gamble
Bull Case

Here are some ways that investors could benefit from investing in Procter & Gamble:

Procter & Gamble's stock is currently trading at $171.08, reflecting a strong performance in the market and indicating investor confidence.
The company has received multiple upgrades from analysts, with DA Davidson raising its price target to $209.00, suggesting significant growth potential.
Procter & Gamble reported earnings per share (EPS) of $1.93, exceeding the consensus estimate, which demonstrates strong financial performance and effective management.
The company has a solid dividend yield of 2.35%, providing a reliable income stream for investors, which is particularly attractive in uncertain market conditions.
With a consensus rating of "Moderate Buy" from analysts, there is a general optimism about the company's future performance, supported by a diverse product portfolio.

Procter & Gamble
Bear Case

Investors should be bearish about investing in Procter & Gamble for these reasons:

The company's revenue decreased by 0.6% compared to the same quarter last year, indicating potential challenges in maintaining growth.
Procter & Gamble has a relatively high price-to-earnings (P/E) ratio of 29.44, which may suggest that the stock is overvalued compared to its earnings.
Insider selling has been significant, with one insider reducing their ownership by over 54%, which could signal a lack of confidence in the company's future prospects.
The company has a current ratio of 0.75, which is below the ideal level of 1, indicating potential liquidity issues that could affect its ability to meet short-term obligations.
Market analysts have mixed ratings, with some downgrading the stock, which may create uncertainty for potential investors.

PG Forecast - Frequently Asked Questions

: According to the research reports of 23 Wall Street equities research analysts, the average twelve-month stock price forecast for Procter & Gamble is $180.45, with a high forecast of $209.00 and a low forecast of $161.00.
: 23 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Procter & Gamble in the last year. There are currently 7 hold ratings, 14 buy ratings and 2 strong buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "moderate buy" PG shares.
: According to analysts, Procter & Gamble's stock has a predicted upside of 7.37% based on their 12-month stock forecasts.
: Over the previous 90 days, Procter & Gamble's stock had 2 upgrades and 1 downgrade by analysts.
: Procter & Gamble has been rated by research analysts at Barclays, DA Davidson, Evercore ISI, Hsbc Global Res, Morgan Stanley, Piper Sandler, Royal Bank of Canada, and Wells Fargo & Company in the past 90 days.
: Analysts like Procter & Gamble more than other "consumer staples" companies. The consensus rating for Procter & Gamble is Moderate Buy while the average consensus rating for "consumer staples" companies is Hold. Learn more on how PG compares to other companies.

Stock Forecasts and Research Tools

Related Companies

Today's Ratings

Top Rated Stocks

More Ratings Tools

URGENT: This Altcoin Opportunity Won’t Wait – Act Now (Ad)

>> Register for the Workshop Now

This page (NYSE:PG) was last updated on 12/21/2024 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Procter & Gamble (PG) Stock Forecast & Price Target